Skip to content

Vitreous Hyper Reflective Dots in Association With Pseudophakic Cystoid Macular Edema

Prospective Analysis of the Correlation Between Hyperreflective Dots in the Vitreous Body and the Appearance of a Pseudophakic Cystoid Macular Edema

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05811182
Enrollment
97
Registered
2023-04-13
Start date
2018-07-01
Completion date
2020-03-01
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystoid Macular Edema Following Cataract Surgery, Vitreous Hyperreflective Dots

Keywords

VHD, phacoemulsification, CME

Brief summary

The aim of this study is to assess the association between vitreous hyper-reflective dots (VHD) and the macular thickness changes following uneventful phacoemulsification. In this prospective study the investigators performed optical coherence tomography (OCT) imaging in patients undergoing cataract surgery preoperatively and postoperatively after 1 week, 1 month and 3 months and analyzed the OCTs for VHDs. The investigators then measured the macular thickness in patients with VHDs and without VHDs and correlated the macular thickness with the number of VHDs.

Interventions

None listed

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients undergoing cataract surgery * minimum age 18 years * phacoemulsification technique * subsequent implantation of a monofocal hydrophobic acrylic intraocular lens

Exclusion criteria

* intraoperative complications including capsule rupture with or without anterior vitrectomy * iris bites * previous interventions including vitrectomy * glaucoma surgery * exudative or dry age-related macular degeneration * presence of diabetes * history or presence of retinal vein occlusion or uveitis * epiretinal glioses

Design outcomes

Primary

MeasureTime frameDescription
vitreous hyperreflective dotspreoperatively until 3 months postoperativelyChange of correlation between occurrence of vitreous hyperreflective dots and the macular thickness

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026